Greg Zaic

Greg Zaic is currently a general partner of Nexus Medical & Technology Capital (“Nexus”), a venture capital firm specializing in healthcare technology investments. He has over 25 years of venture capital investment experience.

Greg has been an active Board member of both public and private corporations, providing assistance and guidance on issues associated with business strategy, corporate expansion, corporate combinations and organizational development. He currently represents Nexus on the Boards of Sabal Medical (hospital medication tracking, recently bought by Swisslog), Zipit Wireless (smart pagers for hospitals, partnered with Verizon), Aethon Inc. (hospital-based robotic logistics), Kiyatec Inc. (3-D cell culture) and Cutanea Life Sciences (dermatological pharmaceuticals, recently bought by Maruho Corporation, Osaka, Japan).